Automated Referral for Frail Elderly
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this observational study is to learn about automated referrals to Perioperative Optimization of Senior Health (POSH). The main question it aims to answer is:
* Do automated referrals to POSH increase the number of people who attend the clinic?
Who Is on the Research Team?
Julia Berian
Principal Investigator
University of Wisconsin, Madison
Are You a Good Fit for This Trial?
This trial is for older adults who are considered frail and are planning to have elective (non-emergency) surgery. Participants must be seniors identified as needing extra support before surgery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Comprehensive Geriatric Assessment
Participants receive a comprehensive geriatric assessment to address frailty before elective surgery
Follow-up
Participants are monitored for implementation outcomes and age-friendly process measures
What Are the Treatments Tested in This Trial?
Trial Overview
The study compares two groups: one gets an automated referral to a special clinic that helps optimize senior health before surgery, while the other receives usual care without this automatic referral.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will receive an automated referral to POSH when screened by the electronic frailty index (a clinical decision support device built into the EHR)
Participants will receive usual care in which surgeons can choose to directly refer patients to POSH.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.